CCL2 and systemic inflammatory response syndrome: We isolated the peripheral blood mononuclear cell (PBMC) from the SIRS model and employed RNA‐seq analysis which indicated that the h‐mIL‐6R mAb treatment could regulate Ccl2 expression, NOD‐like receptor signaling pathway, and TNF signaling pathway.